Zivo Bioscience (ZIVO)

$10.25 0.00 (N/A)
Market Cap 40.77M
Revenue (ttm) 160,000.00
Net Income (ttm) -13.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -8,362.50%
Debt to Equity Ratio 0.00
Volume 400
Avg Vol 1,326
Day's Range N/A - N/A
Shares Out 3.98M
Stochastic %K 53%
Beta 0.19
Analysts Hold
Price Target $12.00

Company Profile

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pe...

Industry: Biotechnology
Sector: Healthcare
Phone: 248 452 9866
Address:
2125 Butterfield Drive, Suite 100, Troy, United States
AmigoMike
AmigoMike May. 29 at 3:40 PM
$ZIVO @trprofit I see you beat me to posting this update over here. Good news in that many thought coccidiosis was dead. Obviously not with a major animal pharma further agreeing to take on a commercial scale test. Fits within the compliance guidelines as we all know these tests have to get to commercial size. I figure results are early August timeframe on this. I'm still of the opinion a pharma deal for coccidiosis makes this a $50 stock. Validation and doors open to more verticals. No real market reaction cause 99.9% of the public and of ZIVO investors haven't seen this update. Of course I anticipate this update will be met with a "yawn" .... i.e. another test. Dunno if this is a new pharma or prior pharma taking the next step .... but commercial scale test .... with intent to find minimum dosage ... determines the economics of commercial viability. Of course we all know this stuff works. Just a matter of money at this point.
0 · Reply
trprofit
trprofit May. 29 at 1:59 PM
$ZIVO They didn't wait until Friday this time. https://www.zivobioscience.com/news-media/project-updates/detail/1581/project-update-may-2026
1 · Reply
nick275
nick275 May. 18 at 7:31 PM
$ZIVO I reviewed the Q1 filing. Expenses significantly cut. Once revenue is generated it will flow right to net profit. Remeber, Zivo has a massive carryover loss to apply against future profits. This is going to pop once a deal is signed. Leadership of this company finally understands Zivo is not a never ending science experiment and needs to be run like a business.
1 · Reply
trprofit
trprofit May. 15 at 6:49 PM
$ZIVO Another Friday Opportunity
0 · Reply
AmigoMike
AmigoMike May. 14 at 7:59 PM
$ZIVO some positive price action today is nice but need execution from mgmt to deliver the prior mentioned revenues.
0 · Reply
nick275
nick275 May. 13 at 3:45 PM
$ZIVO do I really want more 😂
0 · Reply
AmigoMike
AmigoMike May. 12 at 2:18 AM
$ZIVO oh gee. Good Ole Nicky blocked me again. ROFLMAO. Whaaaaatever.
0 · Reply
nick275
nick275 May. 12 at 1:42 AM
$ZIVO missed the opportunity to market their algae as a covid 19 therapeutic. Let’s hope they do not make the same mistake and fail to capitalize on the need for low calorie protein for GLP-1 users. This is a massive market with few established players and plenty of room for a new entrant.
0 · Reply
AmigoMike
AmigoMike May. 11 at 10:21 PM
$ZIVO Apparently some investors don't understand ZIVO has an exclusive with ZWorldwide for distribution of the algae.
0 · Reply
nick275
nick275 May. 10 at 8:53 PM
$ZIVO article sent to me by another investor. Imagine Zivo hitting $200 million in revenue from food additive alone. Obviously huge demand for a product like Zivo. We have seen AG1 become a billion dollar company. Payne needs to step down if he cannot get a deal signed this month. https://archive.is/20260227131138/https://www.forbes.com/sites/chloesorvino/2026/02/26/how-puris-pea-protein-is-fueling-the-ozempic-generation/
3 · Reply
Latest News on ZIVO
No data available.
AmigoMike
AmigoMike May. 29 at 3:40 PM
$ZIVO @trprofit I see you beat me to posting this update over here. Good news in that many thought coccidiosis was dead. Obviously not with a major animal pharma further agreeing to take on a commercial scale test. Fits within the compliance guidelines as we all know these tests have to get to commercial size. I figure results are early August timeframe on this. I'm still of the opinion a pharma deal for coccidiosis makes this a $50 stock. Validation and doors open to more verticals. No real market reaction cause 99.9% of the public and of ZIVO investors haven't seen this update. Of course I anticipate this update will be met with a "yawn" .... i.e. another test. Dunno if this is a new pharma or prior pharma taking the next step .... but commercial scale test .... with intent to find minimum dosage ... determines the economics of commercial viability. Of course we all know this stuff works. Just a matter of money at this point.
0 · Reply
trprofit
trprofit May. 29 at 1:59 PM
$ZIVO They didn't wait until Friday this time. https://www.zivobioscience.com/news-media/project-updates/detail/1581/project-update-may-2026
1 · Reply
nick275
nick275 May. 18 at 7:31 PM
$ZIVO I reviewed the Q1 filing. Expenses significantly cut. Once revenue is generated it will flow right to net profit. Remeber, Zivo has a massive carryover loss to apply against future profits. This is going to pop once a deal is signed. Leadership of this company finally understands Zivo is not a never ending science experiment and needs to be run like a business.
1 · Reply
trprofit
trprofit May. 15 at 6:49 PM
$ZIVO Another Friday Opportunity
0 · Reply
AmigoMike
AmigoMike May. 14 at 7:59 PM
$ZIVO some positive price action today is nice but need execution from mgmt to deliver the prior mentioned revenues.
0 · Reply
nick275
nick275 May. 13 at 3:45 PM
$ZIVO do I really want more 😂
0 · Reply
AmigoMike
AmigoMike May. 12 at 2:18 AM
$ZIVO oh gee. Good Ole Nicky blocked me again. ROFLMAO. Whaaaaatever.
0 · Reply
nick275
nick275 May. 12 at 1:42 AM
$ZIVO missed the opportunity to market their algae as a covid 19 therapeutic. Let’s hope they do not make the same mistake and fail to capitalize on the need for low calorie protein for GLP-1 users. This is a massive market with few established players and plenty of room for a new entrant.
0 · Reply
AmigoMike
AmigoMike May. 11 at 10:21 PM
$ZIVO Apparently some investors don't understand ZIVO has an exclusive with ZWorldwide for distribution of the algae.
0 · Reply
nick275
nick275 May. 10 at 8:53 PM
$ZIVO article sent to me by another investor. Imagine Zivo hitting $200 million in revenue from food additive alone. Obviously huge demand for a product like Zivo. We have seen AG1 become a billion dollar company. Payne needs to step down if he cannot get a deal signed this month. https://archive.is/20260227131138/https://www.forbes.com/sites/chloesorvino/2026/02/26/how-puris-pea-protein-is-fueling-the-ozempic-generation/
3 · Reply
trprofit
trprofit May. 10 at 12:08 PM
$ZIVO Making it appear that they are still treading water.
0 · Reply
AmigoMike
AmigoMike May. 8 at 8:44 PM
$ZIVO Looks like ZIVO spent some time this week submitted the necessary disclosures to OTC Markets to maintain OTC listing. Good news in my book. https://www.otcmarkets.com/stock/ZIVO/disclosure
0 · Reply
trprofit
trprofit May. 8 at 4:35 PM
$ZIVO Here's another Friday opportunity for ZIVO!
1 · Reply
nick275
nick275 May. 8 at 2:04 PM
$ZIVO my guess is announcement soon with a major food processor. These companies are looking to add protein without the calories to their products. Nestle / Zivo !
0 · Reply
nick275
nick275 May. 6 at 3:40 PM
$ZIVO we are going to need an update to get this to $5 this week.
0 · Reply
AmigoMike
AmigoMike May. 5 at 6:24 PM
$ZIVO Luvin' that over $1 spread. L2 looks bone dry on the offer. Certainly could change in a flash but ......... slim pickins
0 · Reply
AmigoMike
AmigoMike May. 5 at 6:20 PM
$ZIVO Thats just the company line response to what they said at the end of March. And Payne shouldn't be responding to nuisance emails. He's got bigger fish to fry.
0 · Reply
trprofit
trprofit May. 5 at 1:06 PM
$ZIVO Response I received early April "The Company will continue its business as usual with more efficient operations. The Company expects revenue in the near future, and with lower overhead moving forward, it anticipates positive cash flow. Based on those expectations, the Board determined it was in the best interests of the shareholders to preserve and accumulate cash"
1 · Reply
nick275
nick275 May. 4 at 5:01 PM
$ZIVO appears Payne out or on his way out. Messages are not being returned. Not surprised since he is old enough to retire and likely does not have much more to contribute to Zivo. Zivo does not need a highly paid CEO unless they quickly bring in new revenue.
0 · Reply
nick275
nick275 May. 3 at 6:09 PM
$ZIVO Zivo an excellent source of protein for those on GLP-1. This alone is a massive market.
0 · Reply
nick275
nick275 May. 1 at 8:27 PM
$ZIVO I’d like to see us end at $5 next week.
0 · Reply
trprofit
trprofit May. 1 at 2:36 PM
$ZIVO Well, it's Friday...The company likes to put out news on Fridays. Could today be the day?
0 · Reply